A detailed history of Black Rock Inc. transactions in Kodiak Sciences Inc. stock. As of the latest transaction made, Black Rock Inc. holds 3,846,827 shares of KOD stock, worth $15.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,846,827
Previous 3,858,621 0.31%
Holding current value
$15.1 Million
Previous $20.3 Million 55.46%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$2.29 - $4.48 $27,008 - $52,837
-11,794 Reduced 0.31%
3,846,827 $9.04 Million
Q1 2024

May 10, 2024

SELL
$3.01 - $7.45 $524,345 - $1.3 Million
-174,201 Reduced 4.32%
3,858,621 $20.3 Million
Q4 2023

Feb 13, 2024

SELL
$1.4 - $3.24 $614,422 - $1.42 Million
-438,873 Reduced 9.81%
4,032,822 $12.3 Million
Q3 2023

Nov 13, 2023

SELL
$1.8 - $7.49 $64,339 - $267,722
-35,744 Reduced 0.79%
4,471,695 $8.05 Million
Q2 2023

Aug 11, 2023

BUY
$4.3 - $9.48 $393,669 - $867,903
91,551 Added 2.07%
4,507,439 $31.1 Million
Q1 2023

May 12, 2023

BUY
$4.81 - $8.88 $616,059 - $1.14 Million
128,079 Added 2.99%
4,415,888 $27.4 Million
Q4 2022

Feb 13, 2023

BUY
$6.52 - $8.05 $1.13 Million - $1.4 Million
174,046 Added 4.23%
4,287,809 $30.7 Million
Q3 2022

Nov 14, 2022

SELL
$7.57 - $12.5 $93,050 - $153,650
-12,292 Reduced 0.3%
4,113,763 $31.8 Million
Q2 2022

Aug 12, 2022

BUY
$5.04 - $9.48 $3.48 Million - $6.54 Million
690,095 Added 20.08%
4,126,055 $31.5 Million
Q1 2022

May 12, 2022

BUY
$7.09 - $89.45 $4.15 Million - $52.3 Million
584,762 Added 20.51%
3,435,960 $26.5 Million
Q4 2021

Feb 10, 2022

BUY
$80.85 - $128.49 $19.4 Million - $30.8 Million
239,749 Added 9.18%
2,851,198 $242 Million
Q3 2021

Nov 09, 2021

BUY
$81.97 - $106.94 $199,351 - $260,078
2,432 Added 0.09%
2,611,449 $251 Million
Q2 2021

Aug 11, 2021

BUY
$77.2 - $126.54 $201 Million - $330 Million
2,609,017 New
2,609,017 $243 Million

Others Institutions Holding KOD

About Kodiak Sciences Inc.


  • Ticker KOD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,040,200
  • Market Cap $205M
  • Description
  • Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...
More about KOD
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.